Search - tctmd.com

Displaying 1 - 20 of 45

Sort: Relevancy | Date

News Daily News

Déjà Vu All Over Again? Results of Intracoronary Stem Cell Study Questioned

Yael L. Maxwell

November 13, 2025

News Daily News

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

L.A. McKeown

November 04, 2025

News Daily News

Regulating Calcium Could Help Regenerate the Heart

Yael L. Maxwell

March 14, 2025

Presentation THT 2025

Stem Cell Based Therapies for HFpEF and HFrEF

Presenter: Sunjay Kushal

February 12, 2025

News Daily News

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Michael O'Riordan

September 27, 2024

News Conference News THT 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Michael O'Riordan

March 08, 2024

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

L.A. McKeown

March 01, 2024

News Opinion CV Team Dispatch

November 2022 News Roundup

L.A. McKeown

November 01, 2022

News Conference News EACTS 2022

CAST-HF: Could Myocardial Shockwave During CABG Yield Cardiac Regeneration?

Shelley Wood

October 12, 2022

News Conference News ESC 2022

First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory

L.A. McKeown

August 26, 2022

News Conference News

Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward

Todd Neale

November 16, 2021

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

News Daily News

James T. Willerson, Revered Clinician, Editor, and Mentor, Dies at 81

L.A. McKeown

September 18, 2020

News Daily News

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

Michael O'Riordan

April 12, 2019

News Conference News AHA 2018

Cell Therapy No Help for Cardiac Recovery in HF Patients With LVADs

Yael L. Maxwell

November 12, 2018

News Daily News

NIH Presses Pause on Cardiac Stem Cell Trial, Further Muddying a Murky Field

Shelley Wood

November 02, 2018

News Industry News

BioCardia Receives New Potency Assay Patent, Providing Further Protection to Autologous Cell Therapy Programs in Heart Failure and Refractory Angina

April 25, 2018

Presentation TCT 2017

CAREMI: A Randomized Double-Blind Trial Evaluating Allogeneic Cardiac Stem Cells In Acute Myocardial Infarction

Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Francisco Fdez-Aviles

October 31, 2017

Presentation TCT 2017

New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells

Presenter: Francisco Fdez-Aviles, Emerson C. Perin, Timothy D. Henry

October 31, 2017

News Daily News

Less Acute MI, More HF: European Task Force Shifts Support for ‘Overhyped’ Cell Therapy Research

Yael L. Maxwell

February 22, 2017

Advertisement

Déjà Vu All Over Again? Results of Intracoronary Stem Cell Study Questioned

PREVENT-TAHA8: Post-MI Intracoronary Stem Cells May Lower HF Risk After STEMI

Regulating Calcium Could Help Regenerate the Heart

Stem Cell Based Therapies for HFpEF and HFrEF

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

March 2024 Dispatch for the CV Team

November 2022 News Roundup

CAST-HF: Could Myocardial Shockwave During CABG Yield Cardiac Regeneration?

First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory

Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

James T. Willerson, Revered Clinician, Editor, and Mentor, Dies at 81

Stem Cell Research—Shattered After Fabrication Scandal—Needs to Rebuild, Says EHJ Editor

Cell Therapy No Help for Cardiac Recovery in HF Patients With LVADs

NIH Presses Pause on Cardiac Stem Cell Trial, Further Muddying a Murky Field

BioCardia Receives New Potency Assay Patent, Providing Further Protection to Autologous Cell Therapy Programs in Heart Failure and Refractory Angina

CAREMI: A Randomized Double-Blind Trial Evaluating Allogeneic Cardiac Stem Cells In Acute Myocardial Infarction

New Products: Ixmyelocel and Allogeneic Mesenchymal Stem Cells

Less Acute MI, More HF: European Task Force Shifts Support for ‘Overhyped’ Cell Therapy Research

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content